Meta-analysis of randomized controlled trials on patent foramen ovale closure vs medical therapy for secondary prevention of cryptogenic stroke
The American Journal of Cardiology | Mar 14, 2018
Smer A, et al. - Patent foramen ovale (PFO) closure as a strategy for secondary prevention of stroke in patients with cryptogenic stroke (CS) was assessed. PFO closure versus medical therapy was shown to be related to a significantly lower risk of recurrent stroke in patients with PFO and CS; however, closure patients more frequently develop atrial fibrillation.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
